| Page 1055 | Kisaco Research
 

Andrew Buchanan

Principal Scientist (ML/Biologics)
AstraZeneca

An experienced team leader and inspiring scientist with an excellent track record of leading innovative drug discovery projects and related technologies. As a leader, member or mentor of teams Andrew has delivered more than 20 CD’s of which three are launched products benefiting patients. Andrew have over 20 years of successful cross-functional and global matrix-team leadership across BioPharm (R&I, CVRM, Neuro, ID) and Onc. With colleagues he has published over 35 original manuscripts and patents.

 

Andrew Buchanan

Principal Scientist (ML/Biologics)
AstraZeneca

Andrew Buchanan

Principal Scientist (ML/Biologics)
AstraZeneca

An experienced team leader and inspiring scientist with an excellent track record of leading innovative drug discovery projects and related technologies. As a leader, member or mentor of teams Andrew has delivered more than 20 CD’s of which three are launched products benefiting patients. Andrew have over 20 years of successful cross-functional and global matrix-team leadership across BioPharm (R&I, CVRM, Neuro, ID) and Onc. With colleagues he has published over 35 original manuscripts and patents.

 

 

Giovanna Lalli

Director of Scientific Affairs
UK Dementia Research Institute HQ

Giovanna Lalli

Director of Scientific Affairs
UK Dementia Research Institute HQ

Giovanna Lalli

Director of Scientific Affairs
UK Dementia Research Institute HQ
 

Clay Schwabe

VP, Business Development
Pria Healthcare

Clay Schwabe

VP, Business Development
Pria Healthcare

Clay Schwabe

VP, Business Development
Pria Healthcare